Introduction
Identifying Mild Cognitive Impairment (MCI) is a critical objective in neurology, as it represents a pivotal window for interventions that may slow the progression of Alzheimer’s disease. While multimodal approaches often incorporate invasive procedures like PET scans or cerebrospinal fluid analysis, there is significant clinical value in maximizing the diagnostic potential of routine, non-invasive MRI scans.
This paper introduces the Centralized Hypergraph Learning (CHL) framework, a novel approach that integrates four distinct MRI sequences: structural T1-weighted imaging, Diffusion Tensor Imaging (DTI), Resting-State functional MRI (RS-fMRI), and Arterial Spin Labeling (ASL). By modeling subjects as nodes within a hypergraph, the CHL method captures high-order relationships between patients that traditional pairwise graphs fail to detect, leading to substantial improvements in diagnostic accuracy.
Methodology: Centralized Hypergraph Learning
The core challenge in multimodal analysis is that different MRI sequences capture unique "views" of the brain. Traditional models often analyze these views in isolation before combining results, which neglects the mutual information—the shared underlying pathological patterns—present across sequences.
The proposed CHL pipeline consists of four primary stages:
- Feature Extraction: Features are extracted from four MRI modalities: brain tissue volumes (T1), structural connectivity (DTI), functional connectivity (RS-fMRI), and blood perfusion (ASL).
- Hypergraph Construction: For each modality, a hypergraph is constructed where subjects are nodes. Unlike standard graphs where edges connect only two nodes, hyperedges in this framework connect a subject (centroid) to its $K$-nearest neighbors, capturing group-level similarities.
- Centralized Learning: This stage employs an alternating optimization strategy. One hypergraph serves as the "core" while others provide "auxiliary guidance," forcing the model to refine relationships in one modality based on the consensus of the others.
- Relevance Fusion: The model learns optimal weights for each centralized hypergraph to produce a final classification of MCI versus Normal Control (NC).
Experimental Setup
The study utilized a clinical dataset of 104 subjects, comprising 41 MCI patients and 63 age-and-gender-matched healthy controls, sourced from the University Hospital of Geneva. Brain data was parcellated into 90 regions of interest (ROIs) using the Anatomical Automatic Labeling (AAL) atlas to generate the necessary connectivity matrices and volume vectors for feature extraction.
Key Results and Discussion
The CHL method was benchmarked against several state-of-the-art techniques, including Multimodal Multitask Learning (M3T) and Manifold Regularized Multitask Feature Learning (M2TFS), using 10-fold cross-validation.
The results demonstrate the superiority of the CHL approach:
- Accuracy Gains: When utilizing all four imaging modalities, CHL achieved an accuracy improvement of 8.65% over M3T and 7.61% over M2TFS.
- Hypergraph Advantage: CHL outperformed its standard graph-based counterpart, Centralized Subject Learning (CSL), by 5.10%, validating the hypothesis that hyperedges are more effective at modeling complex patient populations.
- Multimodal Synergy: The model's performance peaked when all four MRI sequences were used in conjunction, confirming that joint learning effectively leverages complementary information across modalities.
- The Role of ASL: The study highlights ASL as a potent tool. By providing a non-invasive "snapshot" of blood perfusion, it complements structural and connectivity data to enhance diagnostic precision.
Conclusion and Future Directions
The Centralized Hypergraph Learning framework offers a robust, non-invasive means of identifying MCI by effectively fusing information from multiple routine MRI sequences. By moving beyond pairwise relationships to higher-order hypergraph modeling, the method captures subtle pathological signatures essential for early detection.
Future work should focus on validating the model on larger, more diverse datasets such as ADNI to ensure its robustness. Additionally, applying this joint learning framework to longitudinal data could enable the prediction of conversion from MCI to Alzheimer’s disease, further enhancing its clinical utility.
Summary updated